UCB Ventures has 1 portfolio company on record at Recent Funding. It led 1 of the 2 rounds it joined. Its most recent investment on record is Splice Bio's $140M Series B+ round in June 2025, alongside Ysios Capital, Sanofi Ventures, Roche Venture Fund and 5 others. That company is in Health and bio. It has co-invested with NEA, Asabys Partners and Ysios Capital, most often NEA (2 rounds).

What UCB Ventures invests in

• Health and bio · 1 · 100%

How UCB Ventures invests

Share is of the 2 rounds on Recent Funding that name UCB Ventures. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

UCB Ventures portfolio companies

• SSplice Bio$140MSeries B+ · Jun 2025

Most frequent co-investors

• NNEA2 shared rounds · last Jun 11, 2025
• AAsabys Partners2 shared rounds · last Jun 11, 2025
• YYsios Capital2 shared rounds · last Jun 11, 2025
• GGilde Healthcare2 shared rounds · last Jun 11, 2025
• NNovartis Venture Fund2 shared rounds · last Jun 11, 2025
• SSanofi Ventures1 shared round · last Jun 11, 2025
• RRoche Venture Fund1 shared round · last Jun 11, 2025
• EEQT Life Sciences1 shared round · last Jun 11, 2025

Similar investors

• AAccelia Capital1 company · 1 deal in 12 mo
• AAngel Academe1 company · 1 deal in 12 mo
• BBioGenerator Ventures1 company · 1 deal in 12 mo
• BBiospring Partners1 company · 1 deal in 12 mo
• CColossa Ventures1 company · 1 deal in 12 mo
• DDeepWork Capital1 company · 1 deal in 12 mo

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists UCB Ventures, which is a subset of its real portfolio. API: /api/v1/investors/ucb-ventures (get a free API key). More: the most active VC firms and new venture capital funds.